Pravastatin Sodium
Product Images NDC 43353-966

5 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 43353-966). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

40mg (43353 0964 45)

40mg (43353 0964 45)
Label for Pravastatin Sodium 40 mg tablets, containing 45 tablets per bottle. The label includes storage instructions and indicates the medication is repackaged by Aphena Pharma Solutions - Tennessee, LLC, with original manufacturing by TEVA Czech Industries s.r.o. in the Czech Republic. The label displays the NDC number 43353-0964-45 and states RX Only.*
FDA Label Image

80mg (43353 0966 45)

80mg (43353 0966 45)
Label for Pravastatin Sodium 80 mg tablets, package of 45 tablets. The label indicates the product is repackaged by Aphena Pharma Solutions - Tennessee, LLC, with original manufacturing by Teva Pharmaceutical Industries Ltd in Jerusalem, Israel. Storage instructions specify 20-25°C (68-77°F) and dispensing in a USP compliant container. The label includes barcodes and space for batch and expiration information.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (E7235ada Afa0 43c2 94a8 9e0b0f009282 01)

Chemical Structure (E7235ada Afa0 43c2 94a8 9e0b0f009282 01)
Chemical structure of Pravastatin Sodium, depicting the molecular arrangement of atoms and functional groups typical of this active ingredient.*
FDA Label Image

Figure (E7235ada Afa0 43c2 94a8 9e0b0f009282 02)

Figure (E7235ada Afa0 43c2 94a8 9e0b0f009282 02)
A survival distribution plot showing the proportion of subjects without coronary heart disease death or nonfatal myocardial infarction over five years since randomization. The graph compares outcomes between placebo and Pravastatin groups, with the Pravastatin group showing a higher survival proportion. The logarithmic rank p-value is 0.0001, indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.